| GWAS |
- Alzheimer's disease (late onset) ( 30820047
)
- Alzheimer's disease or family history of Alzheimer's disease ( 30617256
33589840
)
- Apolipoprotein A1 levels ( 32203549
)
- Chronotype ( 30696823
)
- Diffusing capacity of carbon monoxide ( 30694715
)
- Family history of Alzheimer's disease ( 30617256
)
- Levodopa-induced dyskinesia in levodopa treated Parkinson's disease ( 32733355
)
- Metabolite levels ( 23823483
)
- Schizophrenia ( 30285260
)
|
- Adult body size ( 32376654
)
- Atrial fibrillation ( 30061737
29892015
)
- BMI (adjusted for smoking behaviour) ( 28443625
)
- BMI in non-smokers ( 28443625
)
- Body mass index (joint analysis main effects and smoking interaction) ( 28443625
)
- Brain morphology (min-P) ( 32665545
)
- Brain morphology (MOSTest) ( 32665545
)
- Caffeine consumption from tea ( 33287642
)
- Cortical surface area (MOSTest) ( 32665545
)
- Diastolic blood pressure ( 27841878
)
- Language functional connectivity ( 34929384
)
- Lateral thalamic nuclei volume ( 34006833
)
- Loneliness (multivariate analysis) ( 27629369
)
- Lung function (FVC) ( 26635082
)
- Orofacial clefts ( 22863734
)
- Periodontitis (Mean PAL) ( 24024966
)
- Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma ( 31028280
)
- Subcortical volume (min-P) ( 32665545
)
- Subcortical volume (MOSTest) ( 32665545
)
- Systemic lupus erythematosus ( 28714469
)
- Systolic blood pressure ( 27841878
)
- Tea consumption ( 31046077
)
- Thrombosis ( 26908601
)
- Ventral thalamic nuclei volume ( 34006833
)
- Vertical cup-disc ratio (multi-trait analysis) ( 31959993
)
- Weight ( 34074324
)
|
